Eyebright Medical Technology (Beijing) Co., Ltd.
SSE:688050.SS
74.16 (CNY) • At close June 12, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| 388.403 | 286.052 | 227.232 | 167.754 | 96.118 | 65.757 | 20.308 | -4.108 | -1.489 |
| Depreciation & Amortization
| 145.592 | 86.459 | 43.35 | 32.038 | 26.666 | 22.395 | 13.75 | 8.057 | 6.027 |
| Deferred Income Tax
| 0 | -10.702 | 7.9 | -8.422 | 0.172 | -13.556 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 15.716 | 12.012 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -206.033 | -177.885 | -39.264 | 11.118 | -0.137 | -39.556 | -19.244 | -23.034 | -11.964 |
| Accounts Receivables
| -127.091 | -103.518 | -45.757 | 1.121 | 18.111 | -14.775 | -8.48 | -22.197 | 0 |
| Inventory
| -86.087 | -85.12 | -22.816 | 3.347 | 1.671 | -24.417 | -20.039 | -5.04 | -2.437 |
| Accounts Payables
| 0 | 21.456 | 21.408 | 15.072 | -20.091 | 13.192 | 0 | 0 | 0 |
| Other Working Capital
| 7.145 | -10.702 | 7.9 | -8.422 | 0.172 | -13.556 | 0.795 | -17.994 | -9.527 |
| Other Non Cash Items
| 19.792 | 42.341 | -6.64 | 4.796 | 0.708 | 1.897 | 17.005 | 23.235 | 4.059 |
| Operating Cash Flow
| 347.754 | 226.266 | 250.132 | 219.296 | 123.354 | 50.494 | 31.82 | 4.15 | -3.367 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -329.483 | -370.342 | -271.032 | -311.217 | -118.73 | -141.611 | -71.806 | -31.533 | -27.619 |
| Acquisitions Net
| -72.3 | -46.599 | -27.383 | -0 | 0.027 | 0.001 | 71.806 | 0.025 | 0 |
| Purchases Of Investments
| -647.342 | -1,140.41 | -2,407.45 | -1,983.108 | -774.982 | -0.001 | -555.299 | -4.065 | -3.944 |
| Sales Maturities Of Investments
| 435.346 | 1,580.049 | 2,377.49 | 1,880.514 | 301.92 | 203.024 | 354.894 | 0 | 0 |
| Other Investing Activites
| 0.014 | -3.675 | 20.533 | -6.558 | 4.05 | 2.563 | -71.805 | 2.025 | -5 |
| Investing Cash Flow
| -613.765 | 19.023 | -307.841 | -420.368 | -587.715 | 63.976 | -272.21 | -33.573 | -36.563 |
| Financing Activities: | |||||||||
| Debt Repayment
| 187.977 | -7.268 | 4.599 | 143.373 | -0.444 | -7.714 | -35.76 | 24.421 | -6.409 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | -18.105 | -5.025 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 18.105 | 5.025 | 0 | 0 | 0 |
| Dividends Paid
| -70.558 | -61.368 | -38.915 | -29.442 | -0.013 | -0.265 | -0.819 | -1.24 | -0.999 |
| Other Financing Activities
| -19.299 | 5.066 | -25.227 | 23.807 | 805.182 | 22.61 | 312.176 | -4.699 | 79.293 |
| Financing Cash Flow
| 98.12 | -63.57 | -65.072 | 137.738 | 804.725 | 14.896 | 276.416 | 18.482 | 71.885 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| -0.019 | 0.04 | -0.042 | -0.635 | 0.148 | -0.006 | -0 | 0 | 0 |
| Net Change In Cash
| -167.91 | 181.76 | -122.823 | -63.968 | 340.513 | 129.36 | 36.025 | -10.941 | 31.954 |
| Cash At End Of Period
| 363.898 | 531.808 | 350.049 | 472.872 | 536.84 | 196.327 | 66.966 | 30.941 | 41.881 |